From Surf Wiki (app.surf) — the open knowledge base
DOV-102,677
Chemical compound
Chemical compound
| elimination_half-life =
DOV-102,677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a triple reuptake inhibitor (TRI), or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). It is the (−)-enantiomer of DOV-216,303, and its (+)-enantiomer is DOV-21,947 (amitifadine).
Instead of being developed for depression, DOV-102,677 is being developed for the treatment of alcoholism.
IC50 values for the SERT, NET and DAT are 129 nM, 103 nM, and 133 nM.
| Compound | Uptake | Binding | 5-HT | NE | DA | SERT | NET | DAT |
|---|---|---|---|---|---|---|---|---|
| DOV-216,303 | 14 | 20 | 78 | 190 | 380 | 190 | ||
| Amitifadine | 12 | 23 | 96 | 100 | 260 | 210 | ||
| DOV-102,677 | 130 | 100 | 130 | 740 | 1000 | 220 |
DOV-102,677 (20 mg/kg IP) increased extracellular levels of dopamine and serotonin in the prefrontal cortex to 320% and 280% above baseline 100 min after administration. Dopamine levels were stably increased for the duration (240 min) of the study, but serotonin levels declined to baseline by 200 min after administration. Norepinephrine levels increased linearly to a maximum of 348% at 240 min post-dosing.
References
References
- (2006). "Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677". Cellular and Molecular Neurobiology.
- (November 2007). "Effect of DOV 102,677 on the volitional consumption of ethanol by Myers' high ethanol-preferring rat". Alcoholism: Clinical and Experimental Research.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about DOV-102,677 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report